2Ahren B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. Clin Endocrinol Metab, 2004, 89(5): 2078-2084
3Zimmet P,Shaw J, Albertit KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med, 2003, 20(9): 693-702
4Wiseman, Alexander, Ronald. Current status of clinical islet transplantation: advances and obstacles. Curr Opin Endocrinol Diabetes, 2004, 11(2): 98-103
5Zhang Y, Atkinson. Gene therapy for type 1 diabetes: metabolism, immunity, islet cell preservation, and regeneration. Curr Opin Endocrinol Diabetes, 2004, 11(2): 91-97
6Bloomgarden ZT. Type 2 diabetes in the young. Diabetes Care, 2004, 27(4): 998-1010
7Engelgau MM. Diabetes diagnostic criteria and impaired Glycemic states: evolving evidence base. Clin Diabetes, 2004, 22(2): 69-70
8Gura T. Diabetes research: new lead found to a possible ""insulin pill"". Science, 1999, 284(5416): 886
9Barnett AH. A review of basal insulins. Diabet Med, 2003, 20(11): 873-885
10Cefalu WT. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care, 2004, 27(1): 239-246
